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Connectivity Density - indicates the average number of connections present between
trabeculae in a specified volume.
Cortical Area - explains the amount of cortical bone per square millimeter.
Cortical Bone - smooth part of bone which is protective in nature and forms the outer
layer of the bone as a shell.
Cortical Bone Thickness- explains the thickness of cortical bone.
Cortical Porosity - describes the porous or empty spaces in the bone.
Degree of Anisotropy - explains the degree of directional organization of bone’s internal
structure when a load is applied in a particular position. A higher DA indicates
increasing disorganization when viewed from a given plane.
Medullary Area - describes the central volume of the bone per square millimeter.
Osteoblast - a mononucleate cell arising from osteoprogenitor cells which is associated
with bone formation.
Osteoclast - a large multinuclear cell associated with the resorption of bone.
Structural Model Index - describes a bone’s relative rod like property. A value of zero
corresponds to pure plates and a value of three corresponds to perfect rods. Negative
values indicate concave like structure and a value of four indicates a sphere. Plate-like
properties are considered desirable and rod-like properties are mostly seen in
ovariectomized models as cross struts are removed and trabeculae are eroded.
Trabeculae - thin strand like structures in cancellous bone.
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Trabecular (Cancellous) bone - the lattice like bone, rigid structure that appears spongy.
Trabecular Number - describes the average number of trabeculae present per mm3.
Trabecular Separation - describes the average separation or air space between trabeculae.
Greater trabecular number (Tb. N) would result in less trabecular separation.















DXA…………………………………………………...Dual Energy X-Ray Absorptiometry
L4………………………………………………………Fourth Lumbar Vertebra
Micro-CT/µCT………………………………………….Micro-Computed Tomography
FE (FE)………………………………………………… Finite Element
SMI……………………………………………………..Structural Model Index






Background to the problem
Bone is a living, growing tissue that is mostly made of collagen, a protein that
provides a soft framework. It also consists of calcium phosphate, a mineral that adds
strength and hardens the framework (1) .
Throughout life, old bone is removed (resorption) and new bone is added to the
skeleton (formation). During childhood and teenage years, new bone is added faster than
old bone is removed. As a result, bones become larger, heavier, and denser. Bone
formation outpaces resorption until peak bone mass (maximum bone density) is reached
around age 30. After that time, bone resorption slowly begins to exceed bone formation.
However continued resorption without adequate formation can lead to thinning and
weakening of the bones to a point whereby they become fragile and break easily, a
condition referred to as osteoporosis.
In the United States, 10 million individuals are estimated to already have the
disease and almost 34 million more are estimated to have low bone mass, placing them at
increased risk for osteoporosis. Of the 10 million Americans estimated to have
osteoporosis, 80% are women and 20% are men (2).
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The bones of the skeleton consist either of cortical (compact) or trabecular
(cancellous) bone. The loss of cancellous bone that occurs with aging is not due to
generalized thinning of the bone plates but is rather caused by complete perforation and
fragmentation of the trabeculae. Osteoporosis is a systemic skeletal disease characterized
by loss of bone mass and microarchitectural deterioration of the trabecular network (3).
According to the National Osteoporosis Foundation, osteoporosis is also known as the
silent disease of aging as bone loss occurs without symptoms until deterioration of the
bone becomes so significant that bone fracture occurs. This disease can be prevented and
treated.
Bone mass gain is mainly related to increases in bone size, that is in bone external
dimensions with minimal changes in bone microarchitecture whereas bone loss results
from thinning of both cortices and trabeculae and from perforation and eventually
disappearance of the latter and significant alteration of the bone microarchitecture (4).
Male osteoporosis is understudied in bone research. As in females, hypogonadism
seems to be the principal risk factor in men that leads to bone loss and increased fracture
incidence (5). Men tend to achieve a greater peak bone size and mass (6) compared to
women and hence have a greater protection once bone loss begins. Some of the risk
factors associated with male osteoporosis include age (bone loss increases with age), race
(Caucasian males have the greatest risk of disease) and genetics (NOF 2004). Other
secondary risk factors include hypogonadism, alcohol abuse, and prolonged steroid
therapy (7).
Osteoporosis is considered a disease of aging, and one of the hypotheses
explaining the aging process is attributed to oxidative stress. Emerging evidence indicates
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that the activation of redox sensitive transcription factors and dysregulated gene
expression due to the age-related oxidative stress could be the underlying cause that links
aging and age related pathological diseases such as osteoporosis (8). Oxidative stress
could lead to progressive bone loss and osteoporosis could be eliminated if oxidative
stress is prevented (9, 10). Oxidative stress is involved in bone resorption due to
generation of superoxide by osteoclasts resulting in bone degradation.
Though there are several treatment options available approved by the Food and
Drug Administration (FDA), the incidence of the disease has escalated with the main
reason being that there is a lack of long term adherence to treatment (11). Hence there is
a need for alternative therapies that have fewer side effects and that are part of the daily
American diet (12).
Grapefruit is a sub-tropical citrus tree which is a rich source of bioactive
compounds called flavonoids and limonoids which have potential health promoting
properties (13).Flavonoids are biologically active compounds found in plants that have
been associated with a decreased risk of some age related and chronic diseases in humans
(14). Flavonoids are present in the pulpy, fibrous parts of major fruits (red grapes,
oranges, pink grapefruit, strawberries and blueberries), fruit products, tea, and soy. Most
common supplemental forms of flavonoids are the citrus flavonoids quercetin, rutin, and
hesperidin. Flavonoids which are polyphenols are effective antioxidants that negate
reactive oxygen species (ROS) and may or may not be colored. Yu et al studied the
antioxidant activity of citrus flavonoids and concluded that several structural features
were linked to the strong antioxidant activity of flavonoids. Citrus flavonoids
demonstrated mild to strong antioxidant activity in comparison to limonoids (15). Some
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of the flavonones found in grapefruit include hesperetin (metabolizes to hesperidin),
naringenin (metabolized from naringin) and eriodictyol (16).
Grapefruit contains compounds such as naringin, naringenin, and 6,7-
dihydroxybergamottin that act by blocking the activity of the cytochrome P-450 (CYP)
3A4 isoenzyme in the intestinal wall, thereby preventing the presystemic first-pass
metabolism of a wide range of drugs (17). Calcium channel antagonists, neuropsychiatric
medications, statins, and antihistamines are just a few of the drug classes whose actions
are significantly affected by the consumption of grapefruit and grapefruit juice. Patients
and other health care professionals need to be educated about potential drug interactions
with grapefruit juice (18).
Grapefruit juices contain large quantities of bioactive compounds, which
guarantee their high antioxidant potential, and the positive influence on plasma lipid
metabolism and plasma antioxidant activity could make fresh grapefruit juice a valuable
supplement for disease-preventing diets (19).
Research Objectives
The principal objective of this study was to determine the effects of feeding
grapefruit pulp on the microarchitecture and strength of bone in an orchidectomized rat
model of male osteoporosis.
The specific aims of the experiment include:
1. To examine the dose dependent effects of grapefruit in preventing bone loss by
assessing bone mineral area (BMA), bone mineral content (BMC) and bone
mineral density (BMD) in a rat model for male osteoporosis.
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2. To determine the dose dependent role of grapefruit pulp in preventing loss of
bone structure by assessing trabecular microstructural properties of the proximal
tibia and the fourth lumbar vertebra.
3. To evaluate the dose dependent effect of feeding grapefruit pulp on the strength of
bone in a rat model of osteoporosis using finite element analysis.
Hypothesis
The hypothesis of this study is that feeding grapefruit pulp that has antioxidant
properties will prevent bone loss in an orchidectomized rat model of male osteoporosis.
Limitations
Unlike men who experience a gradual decline of gonadal hormones over time,
orchidectomy induces an abrupt decrease in gonadal hormones in male rats. However, the
desired hormonal deficiency to induce bone loss was achieved in this model.
Although, the orchidectomized rat model is considered acceptable for studies
relevant to osteoporotic men, the findings of this study cannot be extrapolated directly to
humans due to differences in the bone metabolism between the two species. Rats have
minimal haversian systems in cortical bone thus making the pattern of bone remodeling
in rats and humans different. However, the results of this study should provide
information to warrant clinical trials to determine the use of grapefruit pulp as a treatment
option for male osteoporosis.
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Format of thesis
Chapter IV of this thesis is written in the form of a manuscript for submission to
Journal of Nutrition using their authors’ guidelines. The remaining chapters are based on




Bone is a composite material composed of an organic and inorganic phase. The
organic phase is synthesized by osteoblasts, and the inorganic phase is composed of
calcium phosphate (20). The development of bone begins before birth and formation
predominates until approximately the end of the second decade of life (21, 22).
Osteoblasts are bone cells that deposit mineral salts onto a collagen matrix and increase
bone mass (23) . Osteoclasts are cells responsible for bone resorption and are the only
cell type able to breakdown the mineralized matrix. The osteoclasts foster bone modeling
during growth and bone remodeling during adulthood hence playing a crucial role in
bone physiology. Chondrocytes, the cells in endochondreal skeleton, deposit an
extracellular matrix that is cartilage specific and help in the repair of degraded collagen
matrix (24).
Osteoporosis is a systemic skeletal disease characterized by low bone mass as
well as microarchitectural deterioration of bone tissue, which leads to an increase in bone
fragility and susceptibility to fractures (25). Osteoporosis results from defective
remodeling either when there is enhanced osteoclastic activity or decreased osteoblastic
activity resulting in a net bone loss (26).
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Epidemiology of osteoporosis
Bone loss with age is inevitable and universal, occurring in all skeletal sites, all
races and cultures and in both sexes (27). The World Health Organization defines
osteoporosis as a condition where the BMD is greater than 2.5 standard deviations below
the young adult reference mean (WHO 1994). The National Osteoporosis Foundation
estimates that 10 million Americans are already afflicted with osteoporosis and another
34 million individuals have low bone mass putting them at risk of osteoporosis related
fractures. It is estimated that one in two women and one in eight men over the age 50 will
have an osteoporosis related fracture (28). The annual expenditure for treating
osteoporosis related fractures was $17.5 billion in 2002 (29) and is projected to exceed
$60 billion by the year 2020 (30).Risk factors for the development of osteoporosis
include genetics, sex, race, menopause, inadequate nutrition, use of medications such as
glucocorticoids and lifestyle factors such as smoking and inappropriate strenuous
exercise.
Estrogen deficiency is critical to the pathogenesis of osteoporosis as is evident by
the fact that postmenopausal women who have naturally declining estrogen levels are at
the greatest risk for developing the disease (31). Estrogen is critical for epiphyseal
closure in puberty in both sexes and regulates bone turnover in men as well as women. It
has more effect than androgen in inhibiting bone resorption in men although androgen
may still play a role (32).
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Bone remodeling
Bone is a dynamic tissue that constantly undergoes remodeling although growth
and modeling of the skeleton have been completed. Remodeling of the bone involves
localized removal of old bone (resorption) and replacement with newly formed bone.
Bone remodeling occurs in small packets of cells called basic multicellular units which
turn bone over on multiple bone surfaces (33). The process is regulated by biochemical
and mechanical factors (34). Two principal cell types are found in the bone, the osteoclast
and the osteoblast which are the major effectors in the turnover of bone matrix (35).
Osteoblasts lay down bone matrix that ultimately becomes mineralized in a well
regulated manner (36, 37) .These cells then either undergo apoptosis or become buried
into the matrix to form osteocytes. The osteocytes express receptors for estrogen and
vitamin D in their nuclei (38). Osteoclasts, which are multinucleated cells found in
clusters or alone, are modulated by interleukin-1(IL-1), IL-3, IL-6, IL-11, TNF-α, and
colony stimulating factors. The osteoclasts attach to the endosteal bone surface and create
a tight seal and then secrete acid that solublizes the hydroxyapatite crystals and exposes
the bone matrix. Digestive enzymes then dissolve the protein matrix and liberate
previously deposited growth hormones and collagenases (39). Once resorption is
completed the resorptive cavity becomes refilled with osteoblasts that initiate formation
hence creating a repeating cycle.
Remodeling of Cortical Bone: Cortical bone which comprises 85% of the total
bone in the body is regulated by the formation of periosteal bone, by remodeling within
the haversian systems and by endosteal bone resorption. Endosteal bone resorption leads
to increased porosity of the bone. Cortical bone loss begins probably after the age of 40,
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and there is an accelerated loss of bone 5-10 years after menopause. The loss of cortical
bone is the main predisposing factor for fractures that occur at the hip and around the
wrist (40).
Remodeling of Cancellous Bone: In spite of cancellous bone comprising only
15% of the skeleton, mainly in the vertebral column, it is the main determinant of spinal
osteoporotic fractures. The loss of cancellous bone that occurs with aging is not simply
due to generalized thinning of the bone plates but due to complete perforation and
fragmentation of trabeculae (40).
Bone remodeling is regulated by systemic hormones and local factors. The
hormones regulate the synthesis, activation and effects of the local factors that have a
direct action on cellular metabolism. Hormones also modify the replication function of
the osteoclasts and osteoblasts (41).
Although the main function of bone remodeling is not fully understood, the two
most common reasons attributed to it are that (1) it serves as a means of accessing
minerals and growth factors stored in the bone but needed elsewhere and (2) it provides a
replacement for mechanically compromised bone (42).
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Changes in bone with age
The primary cause of osteoporotic fractures in the elderly is age-related bone loss
(43, 44). Bone loss begins approximately at the age of 40 years and progresses linearly at
a rate of 0.5 to 1% per year. Hence, by 70 years of age as much as 30 % of bone loss is
accrued. This type of bone loss results in increased porosity in cortical and trabecular
bone, decrease in mineralization and finally increases the risk of fracture (45, 46).
Most of the studies on age-related bone loss have focused on postmenopausal
women since women start losing bone earlier than men. However, changes in bone mass
with age are also observed in the male skeleton. Between the ages of 20-30 years (early
adulthood), bone loss begins in women after the growth of long bones is stopped due to a
negative balance in the remodeling process (47). Many studies have shown that the onset
of menopause is associated with an increase in turnover and an increase in bone loss. The
rate of bone remodeling doubles at perimenopause and triples after menopause. This rate
of bone remodeling remains high in osteoporosis (48).
At the onset of menopause, estrogen production drops resulting in increased bone
turnover rate (49). Consequently, more resorption cavities on the endosteal surface of
bone are produced with an increase in bone turnover. Deficiency of estrogen increases the
life span of osteoclasts resulting in the resorption of bone being higher than formation. As
a result, net bone loss occurs since bone formation occurs at a slower rate than resorption.
This increase in resorption leads to an increase in the resorption cavities and deeper
resorption lacunae causing a net loss of trabecular connectivity. Loss of trabeculae
changes the microarchitecture of bone leading to a decrease in overall strength of the
bone (50). This negative balance in bone turnover, where more bone is resorbed than
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formed, is linked to a higher rate of cancellous bone loss in women with osteoporosis
(51). Eventually, rapid loss of bone after menopause results in the complete destruction
of some structural trabecular elements. The remaining trabecular elements show a
reduced thickness due to the continuous loss of trabecular bone leading to further
trabecular architecture deterioration (52, 53).
Cortical thinning and an expansion of marrow cavity is another important
contributing factor in human osteoporotic fractures at the femoral neck (54, 55). An
increase in the cortical area at the femoral midshaft is observed until the seventh decade
of life (56). A study reported by Stein et al (1999) showed that elderly patients did not
have a greater number of pores than younger subjects in the cortical region but elderly
subjects showed larger pores. However, this study did not assess the distribution of
porosity throughout the cortical width or the porosity changes with age (57).
A significant decrease in osteoid mineralization was observed in male Wistar rats
after marrow ablation in femur (58). A decrease in the response of bone cells with age
was observed by bone morphometric and structural studies. Also these rats did not show
a significant decrease in femur strength when compared to their peak values as the force
required to fracture femurs at midshaft did not change with aging. Conversely, ultimate
stress decreased 14% from 12 to 24 months. Ultimate stress is a parameter that
normalizes for differences in bone geometry and size. Other biomechanical properties,
modulus of elasticity, yield strain and ultimate deformation, were not significantly
affected by age. Although the tissue strength increased with age, the strength of the femur
was maintained due to architectural compensations. Based on these findings the authors
concluded that bone status was compromised in the aged male rat (59).
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Male osteoporosis
Preventive medicine for elderly men tends to focus on prostate and bowel cancer
whereas the possibility of bone loss and fractures is usually neglected (60). The
prevalence of low bone mass increases with age in both men and women, an age
associated bone loss. However it is higher for women than men because accelerated bone
loss occurs in the immediate post menopausal period (61). Although women have been
the main focus of osteoporosis research, osteoporosis is a common occurrence in men as
well. The life time risk of experiencing an osteoporotic fracture in men over the age of 50
is 13% (62) which is similar to the risk of developing prostate cancer (63). Hip fractures
become more common with age and between the ages of 85 and 89 years comprise 33%
of all osteoporotic fractures in men and 36% in women (64). The mortality associated
with hip fracture in the elderly is higher in men than women due to more comorbid
conditions at any specific age and lower life expectancy in men (65, 66). A Finnish study
involving 75 -80 year old men and women showed that the risk of fracture was equivalent
at a given BMD level in men and women (67). Also Selby and colleagues reported that
the gender specific T-score of – 2.5 is appropriate in identifying both men and women
likely to have a fracture (68). Although peak bone mass is higher in men than women
because men have bigger bones, the peak bone mineral density is equivalent (69). The
amount of trabecular bone lost at the spine and iliac crest is similar in both men and
women during aging, however, cortical bone loss is less in men due to the reduced
endocortical resorption and increased periosteal formation (70). Elderly men have an
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accelerated bone loss because endocortical resorption and increased cortical porosity
increase the surface available for resorption.
Menopause is the main risk factor for osteoporosis in women. The reason is
attributed to estrogens that preserve bone by restraining the production of cytokines that
promote bone resorption. Loss of estrogen at menopause removes the restraint and
promotes the osteoclastic bone loss. In contrast to postmenopausal osteoporosis in
women, the mechanism of age related bone loss in men has been less studied (Wang
2001). Part of the loss in bone has been linked to gonadal hormone deficiency (71).
Serum total and free testosterone levels have been reported to be significantly lower in
elderly men with hip fractures. In contrast to women, bone remodeling rate in men, as
judged by indices of bone turnover, remains low in midlife and is variably increased in
advanced age.
Androgen receptors have been found in osteoblasts, bone marrow stromal cells,
osteocytes, hypertrophic chondrocytes and osteoclasts (72).These findings provide
evidence that testosterone has a direct effect on male skeletal health.
Studies involving cross-sectional, longitudinal and direct interventional studies
have established the key role that estrogens play in bone metabolism in men, young and
old. Testosterone is important in the male skeleton for sexual dimorphism at the time of
puberty. In adult men, it may also contribute to inhibition of bone resorption and the
maintenance of bone formation, both directly and by serving as a substrate for
aromatization to estrogen (73). Male osteoporosis has become a big problem due to the
potential for longer life expectancies leading to an increased number of elderly
individuals.
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The orchidectomized rat as a model for male osteoporosis
Animal models show similar age related changes to humans which include
changes in tissue function at the level of the whole organ and tissue as well as cellular
and subcellular levels (74).Although an animal model of age-related bone loss may not
precisely replicate the human situation, it may be useful for studying certain aspects of
the bone loss (75). Rats are commonly used as animal models of human diseases because
they are easily available, relevant and appropriate. Wang and colleagues recommend the
use of the Sprague-Dawley rat as a model of male osteoporosis to study potential
preclinical therapies of age related bone loss in men as well as to study the effects of
aging on circulating sex hormones and the effect of therapy with female steroid hormones
on bone in men.
In a study by Audran et al. the orchidectomized (ORX) rat was used to simulate
male osteoporosis due to hypogonadism. Significant bone loss was found due to
increased bone resorption with/without reduced bone formation using histomorphometric
methods (76). The orchidectomized rats showed significant reductions in trabeculae
number and an increase in trabecular separation, both of which are signs of compromised
trabecular connectivity (77).
Another group investigated the effects of androgen deficiency and androgen
replacement on bone density in 14 and 17 month old male rats. Bone mineral content
(BMC) and density (BMD) measured with DXA were not decreased one month after
orchidectomy but were lowered four months after orchidectomy by 10% and 8%
respectively (78).
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Treatment options for male osteoporosis
As the magnitude and character of osteoporosis in men became apparent, so did
the awareness that few data were available concerning its treatment. For some time, male
patients were managed with extrapolations of treatments for women (79). Some of the
options considered before any therapeutic regimen include lifestyle management such as
a calcium rich diet, limited alcohol consumption, smoking cessation, adequate exercise
and treatment of secondary causes of osteoporosis (80).
Other treatment options include bisphosphonates which are used in the prevention
and treatment of osteoporosis due to glucocorticoid excess or hypogonadism. The most
commonly used bisphosphonates include alendronate and trials are underway with
risedronate though it has shown positive effects on BMD (81). The use of parathyroid
hormone (PTH) seems to have excellent effects on BMD. The increase in BMD induced
by PTH is as marked in those with low testosterone levels as in eugonadal men (82).
Hypogonadal men, when treated with sex steroid therapy such as testosterone have
restoration of both serum testosterone and estradiol to levels of eugonadal men. A variety
of trials have shown that sex steroid replacement in men with well established
hypogonadism is associated with an increase in BMD (83).
Bone mineral density and fracture risk
Bone strength is determined by bone geometry, cortical thickness and porosity,
trabecular bone morphology and intrinsic properties of bony tissue. Bone strength is
indirectly estimated by BMD using dual energy X-ray absorptionmetry (DXA) (84).
DXA is the most commonly used technique to measure bone mineral density. It uses two
17
X-ray beams of different energy levels to scan the region of interest and measure the
attenuation as the beam passes through bone (85)
Based on various studies that have examined fracture risk in men and women
according to BMD, it can be concluded that the relationship between BMD and fracture
risk changes with age (86). That means the risk of a fracture at a T-score of -2.5 SD at the
age of 50 yrs is lower than the risk at the age of 80 years with the same T-score. These
problems can be overcome by sampling populations at random and expressing risk as a
function of BMD or standardized T-scores and with age adjustment (87).
Approximately 5% of men over the age of 50 years have a BMD of the proximal
femur more than 2 standard deviations below the young normal mean (88). A study by
Orwoll et al found that BMD in the older men was positively related to weight and
negatively related to age, gastrectomy, previous history of fracture and rheumatoid
arthritis (89). Other studies have found that high body mass index and weight gain have
been associated with high BMD and lower rates of BMD loss (90).
The role of androgens on bone in elderly men was studied by Johnell et al who
found that free testosterone levels were independent positive predictors of BMD in total
body, total hip, femur trochanter and arm but not in the lumbar spine. Free testosterone
but not free total estradiol was a positive predictor of total body bone area and bone
mineral concentration. The study concluded that not only estrogens but also androgens
are of importance for bone health in elderly men (91).
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Oxidative stress
Oxidative stress is caused by either an increase in the production of reactive
oxygen species (ROS) and free radicals, or a decrease in the antioxidant defense system.
The free radical theory of aging suggests that ROS cause time-sensitive structural and
functional disorders that can lead to the development of age-related chronic diseases such
as osteoporosis. Oxidative stress is defined as an imbalance in which the concentration of
pro-oxidants is greater than that of antioxidants. In a state of oxidative stress, antioxidants
are low and markers of oxidative damage are abundant. Ways to decrease oxidative stress
include limiting exposure to outside oxidative agents such a smoke, UV light and air
pollution, reducing production of free radicals that are by-products of mitochondrial
respiration and consuming antioxidants.
A study by Hosokawa showed that higher oxidative stress was related with
senescence acceleration and age dependent alterations in cell structure and function (92).
Other studies by Isomura et al have shown that oxidative stress could be involved in the
pathogenesis of metabolic bone diseases such as osteoporosis (93).
Previous studies have shown that certain risk factors for osteoporosis such as
smoking, hypertension and diabetes mellitus are associated with increased oxidative
stress (94). In addition, free radicals are involved in osteoclastogenesis and in bone
resorption (95) in both in vitro and in vivo studies. The major problem in assessing free
radical induced oxidative stress in various diseases has been the limitation in available
assay methods for in vivo measurement of free radical generation or end products of free
radical catalyzed oxidation of lipids (96).
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Muthusami et al studied the effect of ovariectomy on the antioxidant systems of
bone using a rat model (97). They found that there was an increase in hydrogen peroxide
and lipid peroxidation in the femur of ovariectomized rats supporting the notion that
estrogen deficiency activates ROS for the induction of bone loss (98). Apparently
estrogen deficiency causes bone loss through increased expression of cytokines such as
TNF-α, IL-1, and IL-6 in osteoclasts, supportive bone marrow stromal cells, monocytes
and lymphocytes.
Antioxidants
Polyphenolic flavonoids are among a wide variety of phytochemicals present in
the human diet. Flavonoids are low molecular weight, polyphenolic molecules which
occur naturally in fruits, vegetables, legumes and seeds of vascular plants. Basic research
in animal models as well as human studies suggests flavonoid intake may reduce the risk
of several age related chronic diseases (99). Due to their polyphenolic structure,
flavonoids can be potent scavengers of free radicals (100).
Experimental studies on animals or cultured human cell lines support a role for
polyphenols in the prevention of cardiovascular diseases, cancers, neurodegenerative
diseases, diabetes, or osteoporosis. However, it is very difficult to predict from these
results the effects of polyphenol intake on disease prevention in humans. One of the
reasons is that these studies have often been conducted at doses or concentrations far
beyond those documented in humans (101).
Osteoporosis is associated with many etiological causes such as poor nutrition,
increases in cytokines, loss of hormones, and aging. Recently, reactive oxygen species
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(ROS) have been considered to be responsible for the aging process and osteoporosis.
(102).
Vitamin C supplementation has been shown to increase bone mineral density in
post menopausal women in two interventional studies. However, not much is known
about associations between intakes of other antioxidants and bone health especially in
men who are at a substantial risk of osteoporotic hip fractures (103). A study by Zhang et
al found that higher intakes of antioxidants were associated with a lower risk of hip
fractures in those who had ever been smokers (104). Other studies have shown that
smoking accelerates bone loss and increases fracture risk and the adverse effects of
smoking are attributed to increased oxidative stress (105).
Fruits and vegetables contain high amounts of known antioxidants such as
polyphenols , vitamin C, Vitamin E , B-carotene and lycopene (106). Proteggente et al.
and Henn et al have reported that fruits rich in flavones include orange and grapefruit and
that these citrus fruits are second to fruits rich in anthocyanins. These studies are
supported partially by Lichtenhaler as they found citrus juices superior against hydroxyl
and peroxy radicals to have the same capacity as vitamin added juices against
peroxynitrite radicals (107, 108).
Grapefruit as a source of antioxidants
Recent research, carried out by scientists at the Nutrition and Medical Research
Centre at Scripps Clinic in San Diego, found that the simple act of adding grapefruit and
grapefruit juice to the diet aided weight loss. The three-month study showed that adults
who ate half a grapefruit with each normal meal, three times a day, lost 3.6 lbs on average
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compared with people eating a similar diet without grapefruit who lost only 0.5 lbs. The
researchers believe that enzymes in grapefruit affect the way the body deals with sugar
and make it less likely to be laid down as fat.
Certain studies have looked at the antioxidant property of grapefruit and its
advantages for lowering plasma lipid and its interaction with lipid lowering drugs. A
study by Gorinstein et al found that naringin that was isolated from grapefruit had lipid
lowering and plasma antioxidant capacity and grapefruit beneficially influenced plasma
lipid levels and plasma antioxidant capacity (109).
Grapefruit contains compounds that may reduce atherosclerotic plaque formation
and inhibit cancer cell proliferation (110). Naringin is the most abundant flavonoid in
grapefruit and can account for 40-70% of the dry weight of the small fruit (111). It is one
of the flavanones that is a consistent component of grapefruit and found in all varieties of
grapefruit(112). The properties of naringin were studied in rats fed cholesterol, and it was
found to have a plasma lipid lowering effect, a mechanism that involved an increase in
the bile flow, biliary cholesterol and bile acid concentrations. In addition, a significant
increase in the plasma antioxidant capacity was found in the grapefruit diet group (113).
Naringin has also been reported to suppress cytotoxicity and apoptosis induced by H2O2 a
proxidant in mouse leukemia cells (114).
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Antioxidants and bone studies
Not much is known about associations between intake of antioxidants and bone
health particularly in the area of the male skeleton. Two intervention trials involving
vitamin supplementation have shown that vitamin C supplementation increased bone
mineral density in post menopausal women (115, 116). Several studies have reported
bone protective effects of soy protein and soy isoflavones, a good source of antioxidants,
on the female skeleton (117-121). A recent study by Zhang et al investigated antioxidant
intake and the risk of osteoporotic hip fracture and found that increased intake of vitamin
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E, ß- carotene and selenium were associated with reduced risk of osteoporotic hip
fracture in a dose responsive manner among those who had never smoked in a Utah
population (122).
Deyhim et al evaluated the effect of citrus juice on enhancing serum antioxidant
status and prevention of osteoporosis in orchidectomized rats. Their studies revealed that
orchidectomy decreased total antioxidant capacity, femoral density and biochemical
properties whereas orchidectomy plus orange juice and orchidectomy plus grapefruit
juice reversed the orchidectomy induced antioxidant suppression and delayed time-
induced femoral fracture (123)
Bone quality and structural properties
Bone quality is a set of characteristics influencing bone strength (124). These
characteristics include structural properties (geometry and microarchitecture) and
material properties (collagen and mineral) which are affected by bone modeling and
remodeling (125).
The geometry of bone comprises the size and shape of the bone whilst the micro
architecture refers to the trabecular architecture and cortical thickness of the bone
(126).Bone strength also depends on the structure of collagen and the mineral content
(127).
Bone structure or geometrical arrangement is genetically determined and controls
the bone’s ability to adjust and function accordingly with the existing loads of modeling
and remodeling (128). Geometrical arrangement of a bone is one of the factors that
determines the stress within a bone which is a predictor of fracture risk (129, 130).
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Microarchitecture and assessment using the micro CT
Bone microarchitecture describes the cortical bone and the three dimensional
network of trabeculae in the cancellous bone. Three dimensional micro CT data can be
used to assess bone biomechanical properties using finite element analyses (131).
The parameters involved in microarchitecture measurements that help determine
bone strength include trabecular thickness ( Tb Th), trabecular number (Tb N), trabecular
connectivity, degree of anisotropy (DA) as well as thickness and porosity of the cortical
bone (132). Analysis using high resolution CT microstructure was more useful in
identifying subjects at high risk of fracture than bone density measurements using DXA
(131).
Biomechanical properties and assessment using finite element analysis
The finite element analysis model can be generated using the micro CT images
that provide three dimensional geometric details and information about the material
properties. The three dimensional images are developed from high resolution images
obtained from a region of interest of the bone. The images from the micro CT are
digitized and stacked in order to rebuild the original structure of the model in a 3D
model. Compression testing is simulated on the region of interest and apparent stiffness,





Animals and treatment groups
Three-month–old male Sprague-Dawley rats were maintained on a 12 hr
light/dark cycle in an environmentally controlled animal laboratory and acclimated with a
common control laboratory diet for 2 days. The animals were then divided into four
weight-matched groups using a complete randomized design. One group of rats was sham
operated (SHAM) and the other three groups were orchidectomized (ORX). All rats
received a common control diet for 3 days of recuperation from the surgery. Thereafter,
treatment intervention (Table 1) began for 57 days. Guidelines for the ethical care and
treatment of animals from the Animal Care and Use Committee of Texas A&M
University-Kingsville were strictly followed.
Table 1. Experimental groups
Surgery and
Treatment group
n Day 1-3 Day 4-60
SHAM 11 Control diet Control diet
ORX 15 Control diet Control diet
GF5 11 Control diet Control diet + 5% grapefruit
pulp
GF10 14 Control diet Control diet + 10% grapefruit
pulp
n=number of rats per treatment GF10 = ORX fed 10% grapefruit pulp
ORX =orchidectomized rat GF5 = ORX fed 5% grapefruit pulp
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Composition of experimental diets
The rats were fed a semi-purified, powdered casein-based diet modification of the
AIN-93M diet (Teklad, Madison, WI; Table 2).
Table 2. Composition of control diet





















Total Calories (Kcal) 3675.0
Total Protein (%) 12.6175
1Vitamin Mixture Composition (AIN-93; Harlan Teklad, Madison, WI).
2
Mineral Mixture Composition (g/Kg mix; Harlan Teklad, Madison, WI). magnesium oxide, 24g, Ferric
citrate, 6.06g; zinc carbonate, 1.65g; manganese carbonate, 0.63g; cupric carbonate, 0.3g; potassium iodate,
0.01g; sodium selenate, 0.01g; ammonium paramolybdate, 0.007g; chromium potassium sulfate 0.275g;
boric acid, 0.0815; sodium fluoride, 0.0635g; nickel carbonate, 0.0318g; ammonium vanadate, 0.0066g.
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All rats were pair-fed to the mean food intake of the SHAM rats.Two treatment
groups received either 5% or 10% grapefruit pulp from day 4-60. Before each feeding,
the food remaining was weighed and the amount ingested was calculated. De-ionized
water was provided ad libitum, and the animals were weighed at the beginning and at the
end of the study which lasted for 60 days.
Surgical orchidectomy procedure
Testes were surgically removed to render the rats sex hormone deficient and to
induce bone loss. Orchidectomy was performed on anesthetized animals using aseptic
techniques. Sham-operated control animals were subjected to the same procedure,
without removing their testes. Briefly, animals were anesthetized using a mixture of
ketamine/xylazine (100/5 mg/kg body weight, respectively) and laid on their back and the
skin of the scrotum was thoroughly cleaned using 70% ethanol and 0.1% betadine. A
small median incision of about 1 cm was made through the skin at the tip of the scrotum.
The subcutaneous connective tissue that was encountered was cleared. A 5 mm incision
was made into the tip of each scrotal sac. The cauda epididymis, testes, vas deferens and
spermatic blood vessels were pulled out. A single ligature was placed around the blood
vessels and the vas deferens was severed distal to the ligature allowing removal of the
testis and the epididymides. The remaining vas deferens and the fat were pushed back
into the sac, and each muscle incision was closed with a single suture before closing the
skin incision with tissue adhesive. Estimated blood loss was <0.5 ml. A heat lamp was
used to keep the rats warm as they recuperated from anesthesia. Following surgery, the
animals were carefully monitored until fully recovered. Thereafter, animals were cared
for and monitored on a daily basis.
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Necropsy
After 57 days of consuming the dietary treatments, the rats were anesthetized with
a mixture of ketamine/xylazine (5 mg and 100 mg per kg body weight, respectively) and
were bled from their abdominal aortas. The tibias and the fourth lumbar vertebrae were
carefully removed, cleaned and stored at -20 degrees Celsius. The samples were then
shipped to Oklahoma State University for analysis using the DXA and µCT.
BMD and DXA scans
All specimens after being received at Oklahoma State University were frozen at
-20 ºC until scanned. The excised tibias and the 4 th lumbar vertebrae were scanned
(DXA, model QDR-4500A Elite, Hologic, Waltham, MA) to assess bone mineral area
(BMA), bone mineral content (BMC) and bone mineral density (BMD). The instrument
was calibrated at each use with a phantom provided by the manufacturer. All DXA
measurements and analyses were performed by the same investigator who was blind to
the dietary/surgical treatments.
Bone microarchitecture using microcomputed tomography (µCT)
The effects of treatments on the tibias and the 4th lumbar vertebrae were evaluated
using the µCT 40 scanner (Scanco Medical, Switzerland). The tibial bone was placed in a
16 mm plastic sample holder in the µCT, supported by sponge on the sides to prevent
movement of the bone. The scout view scan was used to select the region of bone to scan
for 3D imaging. This involved getting 300 images from each tibia and the CT images
were reconstructed in 1024×1024 pixels using a medium resolution and an integration
time of 150ms. The volume of interest was then selected as a region beginning 45 slices
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away from the growth plate and was obtained by contouring every 10th slice and
morphing between each contoured slice.
The lumbar vertebrae were scanned from the caudal to the dorsal end (450 slices;
16.5µm). The VOI was selected to begin 10 slices away from the appearance of the
growth plate at each end of the vertebral body. The parameters of interest obtained by
analyzing the VOI were bone volume fraction or ratio of bone volume over total volume
(BV/TV), trabecular number (Tb N.), trabecular separation (Tb Sp), trabecular thickness
( Tb Th), connectivity density (Conn D) and structure model index ( SMI) .
Finite element analyses
The information obtained from micro computed tomography was used to generate
finite element models (134). The finite element analysis was performed using specialized
computer software in which the microcomputed tomography (µCT) histomorphometric
data was used to simulate compression of the VOI to predict the behavior of the bone in
response to the compression. Analyses were performed on VOI of the tibia and the
fourth lumbar vertebrae. The data on the microarchitecture of the bone was subjected to a
high friction compression test in the z direction. This provided data on average strain,
total force, physiological force, stiffness, size independent stiffness, and average Von
Mises stresses of the trabecular bone. These data predict the strength of the bone
specimen.
Statistical analyses
The data were analyzed using SAS (version 9.1, SAS Institute, Cary, NC).
Significance level was set at P ≤ 0.05. When the generalized linear model procedure
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produced a significant F statistic (p <0.05), Fisher’s least significant difference square
means procedure was used to identify treatment differences.
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Abstract
The aim of this study was to evaluate the effects of enhancing antioxidant status on bone
microarchitecture and strength in a male rat model of osteoporosis. Three month-old male
Sprague-Dawley rats were randomly assigned to four groups. Three groups were
orchidectomized (ORX) and one group had sham surgery (SHAM). Three days post-
surgery, ORX rats were assigned to the following treatments: ORX, ORX + 5%
grapefruit pulp and ORX + 10% grapefruit pulp. The rats were fed a semi-purified,
powdered casein based diet modified from AIN-93M for 2 months. At the end of the
study, blood and bones were collected. The bone samples were assessed for bone density
and microarchitecture using DXA and microcomputed tomography. The data were
analyzed using SAS (version 9.1) and the generalized linear model (GLM) and Least
Significant Differences (LSD) procedures were used to separate treatment differences
(p<0.05). Microarchitectural changes seen in tibia showed a marked improvement in the
10% grapefruit group in certain measures whilst none were seen in the 5% group. ORX
negatively impacted certain measures of bone microarchitecture that included bone
volume fraction, connectivity density, trabecular number and trabecular separation of the
tibial bone. In 4th lumbar trabecular assessment, a dose dependent effect was seen as
ORX + 10% grapefruit pulp rats had significantly improved bone volume fraction,
connectivity density, trabecular number and reduced trabecular separation. FE analysis of
the tibial bone showed that a greater force was required to compress SHAM than any of




Although women have been the main focus of osteoporosis research, osteoporosis
is a common occurrence in men as well. The mortality associated with hip fracture in the
elderly is twice as high in men as women due to more comorbid conditions at any
specific age and lower life expectancy in men (1). Though male osteoporosis is an
understudied topic in bone research (2), reduced testosterone seems to be the principal
risk factor in men that leads to increased bone loss and increased fracture incidence (3).
Several cross-sectional (4) and longitudinal (5) studies have documented a decline in total
and bioavailable circulating testosterone levels with aging in men. More than 60% of
healthy, elderly men over 65 yr of age have free testosterone levels below the normal
values of men aged 30---35 yrs (6). 
 Osteoporosis is considered a disease of aging, and one of the hypotheses
explaining the aging process attributes aging to oxidative stress (7). Certain risk factors
for osteoporosis such as smoking, hypertension and diabetes mellitus are associated with
increased oxidative stress (8). 
Free radicals have been shown to be involved in osteoclastogenesis and bone
resorption in vitro and in rodents (9). Oxidative damage apparently increases with age
and thus may overwhelm the natural repair systems in the elderly (10). Other studies have
found that oxidative stress could be lowered 27-38% (11) by effective nutritional
antioxidants which would possibly delay human aging and age related diseases.
The grapefruit, a tropical fruit that is rich in flavonoids has been shown to reduce
the risk of several age related chronic diseases (12) by scavenging free radicals. Although
grapefruit ingestion has been studied for its beneficial role in lowering plasma lipid levels
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and interactions with lipid lowering drugs, knowledge of the role of grapefruit in
prevention of osteoporosis is limited.
Deyhim et al evaluated the effects of citrus juice on enhancing serum antioxidant
status and the prevention of osteoporosis in orchidectomized rats. Their studies revealed
that orchidectomy decreased total antioxidant capacity, femoral density and biochemical
properties whereas orchidectomy plus orange juice or orchidectomy plus grapefruit juice
reversed orchidectomy-induced antioxidant suppression and delayed time-induced
femoral fracture (12). This follow up study assessed bone mineral density,
microarchitecture and biomechanical properties to determine if feeding grapefruit dose-
dependently prevented bone loss.
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Materials and methods
Animals and treatment groups
Three-month–old male Sprague-Dawley rats were maintained on a 12 hr
light/dark cycle in an environmentally controlled animal laboratory and acclimated with a
common control diet for 2 days. The animals were then divided into four weight-matched
groups using a complete randomized design. One group of rats was sham operated
(SHAM) and the other three groups were orchidectomized (ORX). All rats received a
common control diet for 3 days of recuperation from the surgery. Thereafter, treatment
intervention (Table 1) began for 57 days. Guidelines for the ethical care and treatment of
animals from the Animal Care and Use Committee of Texas A&M University-Kingsville
were strictly followed.
Table 1. Experimental groups
Surgery and
Treatment group
n Day 1-3  Day 4-60
SHAM 11 Control diet Control diet
ORX 15 Control diet Control diet
GF5 11 Control diet Control diet + 5% grapefruit
pulp
GF10 14 Control diet Control diet + 10% grapefruit
pulp
n=number of rats per treatment GF10 = ORX fed 10% grapefruit pulp
ORX =orchidectomized rat
GF5 = ORX fed 5% grapefruit pulp
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Composition of experimental diets
The rats were fed a semi-purified, powdered casein-based modified AIN-93M diet
(Teklad, Madison, WI; Table 2).
Table 2. Composition of control diet





















Total Calories (Kcal) 3675.0
Total Protein (%) 12.6175
1Vitamin Mixture Composition (AIN-93; Harlan Teklad, Madison, WI).
2
Mineral Mixture Composition (g/Kg mix; Harlan Teklad, Madison, WI). magnesium
oxide, 24g, Ferric citrate, 6.06g; zinc carbonate, 1.65g; manganese carbonate, 0.63g;
cupric carbonate, 0.3g; potassium iodate, 0.01g; sodium selenate, 0.01g; ammonium
paramolybdate, 0.007g; chromium potassium sulfate 0.275g; boric acid, 0.0815; sodium
fluoride, 0.0635g; nickel carbonate, 0.0318g; ammonium vanadate, 0.0066g.
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All rats were pair-fed to the mean food intake of the SHAM treated rats. The two
treatment groups received either 5% or 10% grapefruit pulp from day 4-60. De-ionized
water was provided ad libitum, and the animals were weighed at the beginning and at the
end of the study.
Surgical orchidectomy procedure
Testes were surgically removed using aseptic techniques to render the rats sex
hormone deficient and to induce bone loss. Sham-operated control animals were
subjected to the same procedure, without removing their testes. Briefly, animals were
anesthetized using a mixture of ketamine/xylazine (5/100 mg/kg body weight,
respectively). Small incisions were made through the skin of the scrotum and the scrotal
sac. The cauda epididymis, testes, vas deferens and spermatic blood vessels were
isolated. A single ligature was placed around the blood vessels and the vas deferens was
severed distal to the ligature allowing removal of the testis and the epididymides. The
remaining vas deferens and fat were returned to the sac, and the muscle incision was
closed with a single suture before closing the skin incision with tissue adhesive.
Necropsy
After 57 days of dietary treatments, the rats were anesthetized with a mixture of
ketamine/xylazine (5mg and 100 mg per kg body weight, respectively) and were bled
from their abdominal aortas. The tibias and the fourth lumbar vertebrae were removed,
cleaned and stored at -20 º C.
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BMD and DXA scans
The excised tibias and the 4th lumbar vertebrae were scanned (DXA, model QDR-
4500A Elite, Hologic, Waltham, MA) to assess bone mineral area (BMA), bone mineral
content (BMC) and bone mineral density (BMD). The instrument was calibrated with a
phantom provided by the manufacturer. All bones were scanned in water by the same
investigator who was blind to the treatments.
Bone microarchitecture using microcomputed tomography (µCT)
All specimens were frozen at -20 ºC until scanned after being received at
Oklahoma State University. The effects of treatments on the tibias and the 4th lumbar
vertebrae were evaluated using the µCT 40 scanner (Scanco Medical, Switzerland). The
tibia was placed in a 16 mm plastic sample holder in the µCT, supported by sponge on
the sides to prevent movement of the bone. The scout view scan was used to select the
region of bone to scan for 3D imaging. This involved getting 300 images at 16.5µm
intervals from each tibia and the CT images were reconstructed in 1024×1024 pixels
using a medium resolution. The volume of interest was then selected as a region
beginning 45 slices away from the growth plate and was obtained by contouring every
10th slice and morphing between each contoured slice. The lumbar vertebrae were
scanned from the caudal to the dorsal end (450 slices; 16.5µm). The VOI was selected to
begin 10 slices away from the appearance of the growth plate at each end of the vertebral
body. The parameters of interest obtained by analyzing the VOI were bone volume
fraction or ratio of bone volume over total volume (BV/TV), trabecular number (Tb N.),
trabecular separation (Tb Sp), trabecular thickness (Tb Th), connectivity density and
structure model index ( SMI) .
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Finite element analyses
The information obtained from microcomputed tomography was used to generate
finite element models (15). Analyses were performed on the VOI from the tibia and the
fourth lumbar vertebrae. The data on the micro-architecture of the bone was subjected to
a high friction compression test in the z direction. This provided data on average strain,
total force, physiological force, stiffness, size independent stiffness, and average Von
Mises stress of the trabecular bone. These data predict the strength of the bone specimen.
Statistical analyses
The data were analyzed using SAS (version 9.1, SAS Institute, Cary, NC).
Significance level was set at P ≤ 0.05. When the generalized linear model procedure
indicated any significant difference among the means, the Fisher’s least significant
difference procedure was used to identify treatment differences.
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Results
Bone mineral content and density
Bone mineral area and bone mineral content differed significantly amongst groups
in the tibial bones (Table 3). The bone mineral area was highest in the ORX and SHAM
groups and was significantly reduced in the group fed 10% grapefruit pulp. The bone
mineral content followed a similar pattern as the BMA with both treatment groups being
significantly lower than ORX. The bone mineral density tended to show similar trends
(p=0.053) though it was not significantly affected by ORX or by grapefruit feeding. The
lengths of the tibia of the different groups were not significantly different from each other
(p=0.072). None of the treatments influenced bone mineral area, content or density in the
fourth lumbar vertebrae (Table 4) significantly.
µCT analysis
Trabecular architecture of the tibia (Table 5) showed differences amongst the
treatment groups. Total volume (TV) of the trabecular bone sample from the proximal
tibia tended to be lower in the group fed 5% grapefruit and was significantly lower in the
10% grapefruit group compared to both ORX and SHAM. The bone volume (BV) was
highest in the SHAM group and the ORX +10 % grapefruit pulp was not significantly
different from SHAM although it tended to be lower and the ORX + 5% group was lower
than SHAM. The ORX + 5% group showed a significant decrease in bone volume
fraction compared to the SHAM and ORX +10% grapefruit pulp.
The connectivity density was significantly higher in the SHAM than in ORX,
ORX+ 5% and ORX +10% treatment groups. The structural model index and trabecular
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thickness were not significantly different from each other (p=0.32 and p= 0.25
respectively). Trabeculae numbers did not differ significantly amongst the ORX, ORX+
5% and ORX + 10% treatment groups, although the ORX+ 10% treatment group was not
significantly lower than the SHAM group.
Trabecular separation was highest amongst the ORX + 5% grapefruit group
followed by the ORX group. However the ORX +10% grapefruit group was not
significantly higher than the SHAM group.
Analysis of the microarchitectural properties of the lumbar vertebrae (Table 6)
revealed that although total volume and bone volume were not significantly different
amongst the groups the bone volume fraction showed significant differences. The bone
volume fraction was the lowest in the ORX group and increased dose dependently with
the two doses of grapefruit pulp. The ORX +10% group was not significantly lower than
SHAM. Connectivity density was significantly different in the ORX, 5 and 10% groups
from the SHAM group. Connectivity density in the vertebrae was significantly reduced
by ORX and was not restored by either grapefruit treatments. The trabecular number
followed a similar pattern as the connectivity density as it tended to increase dose-
dependently and was highest in the SHAM, followed by ORX +10% and then ORX+ 5%
grapefruit treatment group. Orchidectomy increased trabecular separation which was
highest amongst the ORX group and lowest in the SHAM group, supporting a dose
dependent pattern.
The tibial midshaft cortical bone microarchitecture (Table 7) also showed some
significant results. Although bone volume fraction was not significant, both tissue
volume and bone volume showed similar significant results. The grapefruit fed groups
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were lower than the ORX group. Cortical thickness was increased by ORX but the 10%
grapefruit pulp was not different from the ORX alone. Cortical porosity was not
significantly different amongst the treatment groups. Total bone area and the cortical area
were significantly lower in grapefruit treatment groups than in the ORX group. The
marrow area was highest in the SHAM group and significantly lower in the groups fed
grapefruit pulp.
FE analysis
Finite element models were generated using the µCT analyses and the material
properties of the bone in response to compression were predicted. Both fourth lumbar
vertebrae and proximal tibia were analyzed for strength parameters of physiological
force, average strain, stiffness, size independent stiffness, Von Mises stresses and average
cross section area.
Treatment showed significant effect on the strength of proximal tibia (Table 8).
Greater force was required to compress or crush the bone of the SHAM group compared
to ORX groups, indicating poor bone quality in orchidectomized rats. The groups fed
grapefruit showed a significant reduction in the force required to crush the bone.
Similarly, the size adjusted stiffness (p=0.03) required to deform the bone in the SHAM
group was greater when compared to the ORX +5% and ORX+ 10% groups though did
not differ from the ORX group. There were significant changes in the average cross
section area as the ORX + 10% group differed from SHAM and the ORX group. The
values were lower in the ORX + 10% group compared to the others. Size-independent
stiffness tended to be higher in the SHAM than the treatment groups. Findings on the
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biomechanical properties of lumbar vertebrae did not show any significant changes
(Table 9). The physiological force required for compression of the vertebrae, stiffness
and cross sectional area did not differ in any of the treatment groups. Size-independent
stiffness tended to be lower in ORX and to show a dose-dependent increase with
grapefruit feeding.
Discussion
The use of grapefruit for the prevention of male osteoporosis is an appealing
natural alternative to taking pills everyday. In this study, freeze dried grapefruit pulp
prevented some aspects of microarchitectural deterioration and loss of strength in bone.
The main method of action is not known, though it might be through the presence of
antioxidants that enhance bone formation and reduce bone resorption. Flavonoids are
bioactive compounds found in grapefruit that improve bone health by improving
antioxidant status, hence protecting bone resorption and enhancing bone formation. This
is a follow up study on the work done by Deyhim et al (14) showing that lack of
testosterone led to a decrease in antioxidant status, thus potentiating oxidative stress in
the orchidectomized rats. In addition, they also concluded that drinking citrus juice
prevented the decrease in serum antioxidant capacity in ORX rats. They also found a
marked effect in decreasing bone resorption in the orange group versus the grapefruit
group. Their finding correlates with some of the measures of bone structure and
biomechanical properties found in this study.
Although in this study, some trends were seen to improve bone structure dose
dependently, this was not a consistent finding through out the study. Orchidectomy
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negatively impacted some of the measures of bone though treatment with grapefruit pulp
did not always reverse bone loss. Some of the limitations of the study are the age of the
rats used and also the duration of study. It would be recommended to use a much older
population of rats so that bone changes are significantly noticed. In addition feeding time
should last at least four months to appreciate noticeable changes in bone structure.
Conclusion
We conclude from the above study that there are certain beneficial effects of
grapefruit in preventing bone loss as evident by assessing trabecular microstructural and
biomechanical properties of the proximal tibia and the fourth lumbar vertebra. The effects
of a lower dose of grapefruit could not be easily discerned from our study although some
of the data suggests that grapefruit could be a potential candidate as a natural alternative
to prevention of male osteoporosis as treatment options for males are few and often have
side effects.
Further research is required to determine the effects of feeding grapefruit pulp to
orchidectomized rats in an older population and for a longer time frame.
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Bone mineral area (BMA), bone mineral content (BMC) and bone mineral density (BMD) determined by DXA of tibia of rats fed







N=11 N=15 N=11 N=14
Length (mm) 44.85 ± 0.38 44.98 ± 0.31 44.47 ± 0.27 43.92 ± 0.28 0.072
BMA (cm2) 1.96 ± 0.03a 2.02 ± 0.02a 1.91 ± 0.02ab 1.79 ± 0.08b 0.0114
BMC (g) 0.462 ± 0.010ab 0.478 ± 0.008a 0.437 ± 0.006b 0.438 ± 0.009b 0.0017
BMD (g/cm2) 0.235 ± 0.002 0.236 ± 0.002 0.229 ± 0.002 0.235 ± 0.002 0.053
1Measurements based on DXA scans.
2Values are means ± SEM .
a-cMeans ± SEM within a row not sharing a common letter differ significantly, (P <0.05).
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TABLE 4
Bone mineral area (BMA), bone mineral content (BMC) and bone mineral density (BMD) determined by DXA of lumbar vertebrae of
rats fed grapefruit pulp
Measurements based on DXA scans.


























Trabecular bone morphology of proximal tibia from sham operated and orchidectomized rats fed diets containing 5% or 10% freeze
dried grape fruit 1, 2










Total Volume, mm3 29.40±0.91a 29.86±0.67a 28.51±0.69ab 27.15±0.59b 0.0356
Bone Volume, mm3 4.80± 0.36a 4.24±0.20a 3.49±0.31b 4.08±0.18ab 0.0159
Bone Volume
Fraction, %
16.35± 1.2a 14.25±0.6ab 12.28±1.1b 15.08±0.7a 0.0290
Connectivity
Density,1/ mm3
52.6± 5.2a 38.8±2.8b 32.6±4.9b 40.7±2.4b 0.0083
SMI 2.23±0.09 2.35±0.04 2.41±0.09 2.29± 0.05 0.3284
Trabecular
Number,1/mm
3.40±0.19a 2.96±0.13b 2.74±0.19b 3.04± 0.09ab 0.0410
Trabecular Thickness,
mm
0.073±0.001 0.075±0.001 0.072±0.002 0.076±0.001 0.2475
Trabecular
Separation, mm
0.29±0.02b 0.34±0.02ab 0.38±0.03a 0.32±0.01b 0.0426
1Measurements based on µCT analysis.
2Values are means ± SEM.
a-cMeans ± SEM within a row not sharing a common letter differ significantly, (P <0.05)
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TABLE 6
Effects of feeding grapefruit pulp on trabecular bone in sham operated and orchidectomized rats fed diets containing 5% or 10%
freeze dried grape fruit on the lumbar vertebrae 1, 2
1Measurements based on µCT analysis.
2Values are means ± SEM .








N=11 N=15 N=11 N=14
Total Volume, mm3 19.79±0.8 21.97±0.88 22.76±1.18 21.96±0.67 0.1634
Bone Volume, mm3 4.461±0.2 3.98±0.17 4.50±0.26 4.69±0.32 0.2097
Bone Volume
Fraction, %
22.7±1.1a 18.3±0.7b 19.9±0.8bbc 21.2±1.0ac 0.0096
Connectivity
Density 1/ mm3
44.2±2.8a 34.6±2.2b 35.8±1.8b 35.9±1.9b 0.0200
SMI 0.86±0.11
b
1.22±0.06a 1.08±0.07a 1.05±0.09ab 0.0399
Trabecular
Number,1/mm
3.225±0.0 2.726±0.097b 2.841±0.097b 2.955±0.088b 0.0041
Trabecular Thickness,
mm





0.374±0.014a 0.353±0.014ac 0.336±0.012ac 0.0057
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TABLE 7
Effects of feeding grapefruit pulp on tibia midshaft cortical bone architecture in sham operated and orchidectomized rats fed diets







N=11 N=15 N=11 N=14
TV [mm3] 2.59 ± 0.04a 2.60 ± 0.04a 2.42 ± 0.05b 2.44 ± 0.05b 0.0052
BV [mm3] 2.50 ± 0.03a 2.53 ± 0.03a 2.34 ± 0.04b 2.37 ± 0.05b 0.0043
BVTV [%] 96.55 ± 0.48 97.16 ± 0.08 96.92 ± 0.12 97.11 ± 0.06 0.2237
CortTh [mm] 0.618 ± 0.011b 0.643 ± 0.008a 0.615 ± 0.007b 0.639 ± 0.008ab 0.0501
Poros [%] 3.45 ± 0.48 2.84 ± 0.08 3.08 ± 0.12 2.89 ± 0.06 0.2237
Bone Area [mm2] 5.24 ± 0.08a 5.26 ± 0.07a 4.88 ± 0.09b 4.93 ± 0.11b 0.0052
Cort Area [mm2] 3.81 ± 0.07ab 3.93 ± 0.05a 3.62 ± 0.05b 3.74 ± 0.07b 0.0092
Marrow Area [mm2] 1.43 ± 0.06a 1.33 ± 0.04ab 1.26 ± 0.06bc 1.18 ± 0.06c 0.0186
1Measurements based on µCT analysis.
2Values are means ± SEM .
a-cMeans ± SEM within a row not sharing a common letter differ significantly, (P <0.05)
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TABLE 8
Effects of feeding grapefruit pulp on the tibial biomechanical properties in sham operated and orchidectomized rats fed diets








N=11 N=15 N=11 N=14
Average strain 0.258±0.013 0.245±0.013 0.230±0.015 0.227±0.008 0.3233
Physiological
force [N]
24.6±3.2a 20.1±1.8ab 15.6±1.9b 17.6±0.9b 0.0276
Stiffness
[N/m × 103]
4964609±640752a 4054303±369385ab 3140809±391375b 3557430±201580b 0.0276
Cross sectional
area
17.79±0.55a 18.07±0.40a 17.26±0.42ab 16.44±0.36b 0.0356
Independent
stiffness [N/m]
458±57a 369 ±31ab 299±36b 359±21ab 0.0492
Von Mises
stress [MPa]
20.66±1.59 23.04±1.28 41.86±2.27 24.16±1.17 0.1423
1Measurements based on FE analysis.
2Values are means ± SEM .
a-cMeans ± SEM within a row not sharing a common letter differ significantly, (P <0.05)
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TABLE 9
Effects of feeding grapefruit pulp on the vertebral biomechanical properties in sham operated and orchidectomized rats fed diets
containing 5% or 10% freeze dried grape fruit 1, 2
Bone Structure
Variable
SHAM ORX ORX+5% ORX+10% P value
N=11 N=15 N=11 N=14
Average strain 0.156±0.019 0.110±0.012 0.140±0.016 0.139±0.017 0.2344
Physiological
force [N]
4.4±0.7 3.2±0.3 4.0±0.5 4.7±0.6 0.1606
Stiffness
/ 103
325035±50972 236854±35057 271378±35891 316106±41344 0.3714
Cross sectional
area
4.14±0.18 4.75±0.27 4.62±0.23 4.46±0.10 0.2168
Independent
stiffness [N/m]
377±54 228±24 296±42 347±47 0.0653
Von Mises stress
[MPa]
16.71±1.19 19.30±1.19 17.08±1.13 17.44±1.88 0.5655
1Measurements based on FE analysis.





The study found that feeding grapefruit pulp prevented bone loss in some
measures of bone microarchitecture by improving the antioxidant status in the
orchidectomized rats.
Conclusion
We conclude from the above study that there is a positive effect of grapefruit in
preventing bone loss as evident by assessing certain measures of trabecular
microstructural and biomechanical properties of the proximal tibia. In addition the
microCT was found to be more sensitive in assessing the changes due to grapefruit diet as
compared to the DXA machine.
These data suggest that grapefruit could be a potential candidate as a natural
alternative to prevention of male osteoporosis. Treatment options for males are few and
often have side effects.
Although further research is required to determine the results of this animal
studies in human subjects with a probable higher dose of grapefruit, these results are
promising in grapefruits ability to reduce bone loss in an osteoporotic model.
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Recommendations
Taking into consideration the findings of this study, there are a lot of research questions
to be addressed about the exact mechanism of action of these antioxidants. Further
research needs to look at urine and serum biochemical markers of bone turnover
including deoxypyridinoline crosslinks and osteocalcin. In addition dose dependent
studies need to be done with higher concentrations of grapefruit to seek if this has an
impact on greater bone loss prevention.
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